BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18072858)

  • 21. Protective effect of liposome-mediated glial cell line-derived neurotrophic factor gene transfer in vivo on motoneurons following spinal cord injury in rats.
    Lu KW; Chen ZY; Hou TS
    Chin J Traumatol; 2004 Oct; 7(5):275-9. PubMed ID: 15363220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenoviral vector carrying glial cell-derived neurotrophic factor for direct gene therapy in comparison with human umbilical cord blood cell-mediated therapy of spinal cord injury in rat.
    Mukhamedshina YO; Shaymardanova GF; Garanina ЕЕ; Salafutdinov II; Rizvanov АА; Islamov RR; Chelyshev YA
    Spinal Cord; 2016 May; 54(5):347-59. PubMed ID: 26415641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adeno-associated virus-mediated delivery of glial cell line-derived neurotrophic factor protects motor neuron-like cells from apoptosis.
    Keir SD; Xiao X; Li J; Kennedy PG
    J Neurovirol; 2001 Oct; 7(5):437-46. PubMed ID: 11582516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice.
    Larsen KE; Benn SC; Ay I; Chian RJ; Celia SA; Remington MP; Bejarano M; Liu M; Ross J; Carmillo P; Sah D; Phillips KA; Sulzer D; Pepinsky RB; Fishman PS; Brown RH; Francis JW
    Brain Res; 2006 Nov; 1120(1):1-12. PubMed ID: 17020749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain-derived neurotrophic factor gene transfer with adeno-associated viral and lentiviral vectors prevents rubrospinal neuronal atrophy and stimulates regeneration-associated gene expression after acute cervical spinal cord injury.
    Kwon BK; Liu J; Lam C; Plunet W; Oschipok LW; Hauswirth W; Di Polo A; Blesch A; Tetzlaff W
    Spine (Phila Pa 1976); 2007 May; 32(11):1164-73. PubMed ID: 17495772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model.
    Suzuki M; Svendsen CN
    Methods Mol Biol; 2016; 1382():325-36. PubMed ID: 26611598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice.
    Ayers JI; Fromholt S; Sinyavskaya O; Siemienski Z; Rosario AM; Li A; Crosby KW; Cruz PE; DiNunno NM; Janus C; Ceballos-Diaz C; Borchelt DR; Golde TE; Chakrabarty P; Levites Y
    Mol Ther; 2015 Jan; 23(1):53-62. PubMed ID: 25228069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgene-mediated GDNF expression enhances synaptic connectivity and GABA transmission to improve functional outcome after spinal cord contusion.
    Koelsch A; Feng Y; Fink DJ; Mata M
    J Neurochem; 2010 Apr; 113(1):143-52. PubMed ID: 20132484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy for detached retina by adeno-associated virus vector expressing glial cell line-derived neurotrophic factor.
    Wu WC; Lai CC; Chen SL; Xiao X; Chen TL; Tsai RJ; Kuo SW; Tsao YP
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3480-8. PubMed ID: 12407159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motor Cortex Activity Organizes the Developing Rubrospinal System.
    Williams PT; Martin JH
    J Neurosci; 2015 Sep; 35(39):13363-74. PubMed ID: 26424884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease.
    Bucher T; Colle MA; Wakeling E; Dubreil L; Fyfe J; Briot-Nivard D; Maquigneau M; Raoul S; Cherel Y; Astord S; Duque S; Marais T; Voit T; Moullier P; Barkats M; Joussemet B
    Hum Gene Ther; 2013 Jul; 24(7):670-82. PubMed ID: 23799774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury.
    Kato R; Wolfe D; Coyle CH; Huang S; Wechuck JB; Goins WF; Krisky DM; Tsukamoto T; Nelson JB; Glorioso JC; Chancellor MB; Yoshimura N
    Gene Ther; 2007 Sep; 14(18):1344-52. PubMed ID: 17611585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seizure suppression by GDNF gene therapy in animal models of epilepsy.
    Kanter-Schlifke I; Georgievska B; Kirik D; Kokaia M
    Mol Ther; 2007 Jun; 15(6):1106-13. PubMed ID: 17387333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential transgene expression profiles in rat brain, using rAAV2/1 vectors with tetracycline-inducible and cytomegalovirus promoters.
    Bockstael O; Chtarto A; Wakkinen J; Yang X; Melas C; Levivier M; Brotchi J; Tenenbaum L
    Hum Gene Ther; 2008 Nov; 19(11):1293-305. PubMed ID: 19866492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis.
    Mòdol-Caballero G; García-Lareu B; Herrando-Grabulosa M; Verdés S; López-Vales R; Pagès G; Chillón M; Navarro X; Bosch A
    Neurotherapeutics; 2021 Apr; 18(2):1113-1126. PubMed ID: 33786805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restriction of axonal retraction and promotion of axonal regeneration by chronically injured neurons after intraspinal treatment with glial cell line-derived neurotrophic factor (GDNF).
    Dolbeare D; Houle JD
    J Neurotrauma; 2003 Nov; 20(11):1251-61. PubMed ID: 14651811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reticulospinal plasticity after cervical spinal cord injury in the rat involves withdrawal of projections below the injury.
    Weishaupt N; Hurd C; Wei DZ; Fouad K
    Exp Neurol; 2013 Sep; 247():241-9. PubMed ID: 23684634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of chronically injured spinal cord with neurotrophic factors stimulates betaII-tubulin and GAP-43 expression in rubrospinal tract neurons.
    Storer PD; Dolbeare D; Houle JD
    J Neurosci Res; 2003 Nov; 74(4):502-11. PubMed ID: 14598294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of self-complementary adeno-associated virus serotype 2 as a tracer for labeling axons: implications for axon regeneration.
    Liu Y; Keefe K; Tang X; Lin S; Smith GM
    PLoS One; 2014; 9(2):e87447. PubMed ID: 24498323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Hayes A; Bellantuono I; Aebischer P; Svendsen CN
    Mol Ther; 2008 Dec; 16(12):2002-10. PubMed ID: 18797452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.